Sign in
4

Changes in Ownership

TransMedics Group, Inc. Filed Acc 0000950170-25-079022

Director sold 5,000 shares at $126.45 ($632,250)

  • Director acquired 5,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Basile Edward M · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-05-27 Exercise or conversion : show line 1 in the form 10b5-1 +5,000 $0.70 $3,500 7,866 D
2025-05-27 Sale : show line 2 in the form 10b5-1 −5,000 $126.45 $632,250 2,866 D
Open-market sales · 5,000 sh · avg $126.45 · $632,250

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-05-27 Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (Right to Buy) −5,000 8,285 D
Loading xslF345X05/ownership.xml…